The immune receptor/ligand pair PD-1/PD-L1 constitutes a key inhibitory immune checkpoint system hijacked by cancer to escape destruction by the immune system, thereby highlighting its importance as a target for cancer immunotherapy (152). This evidence concerns the gene CD274 and cancer.